Half of England's health boards impose minimum waits to manage costs, BMJ data shows

Across England, nearly half of the health boards responsible for organizing local medical services have quietly put a floor under how quickly they will treat patients. Seventeen of the thirty-six Integrated Care Boards—the organizations that plan and commission health services for their regions—have imposed minimum waiting times of twelve to sixteen weeks before patients can access routine procedures like hip replacements, knee surgery, and cataract removal. The policy is deliberate. It is designed to manage demand and control costs. And it is now public.

The data comes from Freedom of Information requests sent by The BMJ to all thirty-six boards in England. Thirty-five responded. Of those, seventeen—nearly half—confirmed they had introduced some form of minimum wait. The remaining seventeen said they had no such policy. One board, NHS North East London, could not say either way.

The minimum waits vary by region and procedure. Two boards—Shropshire, Telford and Wrekin, and West Yorkshire—have set a blanket sixteen-week minimum for all routine procedures. South East London imposes a sixteen-week minimum specifically for cataract surgery. Humber and North Yorkshire uses what it calls a "planning assumption" of sixteen weeks, meaning NHS and private providers working for the health service expect patients to wait that long on average. North East and North Cumbria has set a similar assumption of fifteen weeks for all elective procedures. Six other boards—Birmingham and Solihull, Black Country, Coventry and Warwickshire, Devon, Hereford and Worcestershire, and Somerset—have settled on fourteen weeks as their minimum for all elective work. Others target specific procedures: Leicester, Leicestershire and Rutland imposes fourteen weeks for orthopedics and eye surgery; Thames Valley for cataracts; Dorset for independent surgical providers.

The significance lies in what these waits mean against the NHS Constitution, which sets an eighteen-week maximum from referral to treatment. That standard has not been met nationally since February 2016. A sixteen-week minimum wait leaves only two weeks of buffer before breaching a constitutional promise. Experts warn that some of these policies risk crossing that line entirely.

The human cost is not abstract. Tim Lane, president of the Royal College of Surgeons, described what minimum waits mean in practice: patients who are clinically ready for treatment are made to wait anyway, living with pain, reduced mobility, and anxiety for longer than necessary. They cannot work. They cannot do normal activities. And while they wait, their conditions may worsen, changing what they need and when they need it. The Royal College of General Practitioners called the waits "difficult to justify," particularly when patients could be treated sooner. Sally Gainsbury, a senior policy analyst at the Nuffield Trust think tank, acknowledged that spreading a fixed budget evenly across a population can be rational—but she flagged a deeper problem: there is no clarity on how to do it fairly.

Health boards defending the practice say minimum waits help them use their services, staff, and budgets as efficiently as possible. An NHS spokesperson stated that all patients are still seen in order of clinical need, and that no organization should commission waits that breach constitutional standards. But the data shows that some already do, or come close. The tension is real: the NHS faces genuine financial and capacity pressures. But the solution being deployed—telling patients they cannot be treated until a certain amount of time has passed, even if they are ready—shifts the burden of that pressure directly onto the people waiting for care.